Faslomax
Fulvestrant is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.
MELFALAX INJECTION
Melphalan is an indispensable part of Multiple Myeloma treatment. Being available in oral dosage form, it adds to the convenience of the patient, especially in ‘all oral’ chemotherapy regimens.
CARNUMAX
A cell-cycle phase nonspecific alkylating antineoplastic agent. It is a nitrogen mustard β-chloro-nitrosourea compound. It is used in the treatment of brain tumors and various other malignant neoplasms, Multiple myeloma, Hodgkin’s and Non-Hodgkin’s lymphoma.
PROLEMAX
Leuprolide acetate is a gonadotropin-releasing hormone (GnRH) agonist. Leuprolide acetate is approved for palliative treatment of advanced Prostate cancer.
BENDAMAX
Bendamustine hydrochloride is a bifunctional chemotherapeutic agent with structurally similar to alkylating agents and purine analogues.
BUSULMAX
Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of Chronic Myeloid Leukemia (CML).